-
NAT6 Drives Enterovirus 71 Replication via PI4KB and Organel
2026-04-23
This study identifies N-terminal acetyltransferase 6 (NAT6) as a critical host factor for enterovirus 71 (EV71) replication by regulating PI4KB expression and replication organelle biogenesis. These findings reveal a novel link between protein acetylation, Golgi integrity, and viral propagation, offering new directions for antiviral research.
-
Evaluating Anti-Cancer Drug Responses: In Vitro Method Advan
2026-04-22
Schwartz's dissertation introduces a refined framework for distinguishing between cell proliferation arrest and cell death in in vitro anti-cancer drug testing. By highlighting the limitations of traditional viability metrics, the study provides actionable methodologies to improve the accuracy of preclinical drug evaluation—a development with direct relevance for researchers using agents such as Artesunate.
-
Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp
2026-04-22
Unlock consistent, high-specificity isolation of protein complexes with the Protein A/G Magnetic Co-IP/IP Kit—streamlining workflows for co-immunoprecipitation and antibody purification using magnetic beads. See how recent stem cell research and hands-on troubleshooting insights set this kit apart for protein-protein interaction analysis.
-
HyperFluor 488 Goat Anti-Mouse IgG: Elevating Neuroepigeneti
2026-04-21
HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody from APExBIO drives ultra-sensitive, reproducible protein detection in neuroepigenetic workflows. Discover applied strategies, experimental upgrades, and troubleshooting guidance that unlock the full potential of fluorescently labeled secondary antibodies in m6A-mediated memory research.
-
Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons
2026-04-21
This study develops a scalable human sensory neuron model from inducible pluripotent stem cells (hiPSCs) to recapitulate latent and reactivatable infection by herpes simplex virus 1 (HSV-1). The platform enables direct investigation of neuron-intrinsic mechanisms underlying HSV-1 latency and reactivation, bridging a critical gap left by animal models.
-
High-Yield In Vitro RNA Synthesis: Rethinking Translational
2026-04-20
This thought-leadership article explores how mechanistic understanding of RNA modifications—such as pseudouridine incorporation—can be strategically leveraged in translational research, especially in RNA therapeutics and vaccine development. By linking the latest epitranscriptomic findings with advanced tools like the HyperScribe™ T7 High Yield RNA Synthesis Kit, we illuminate new directions for experimental design, validation, and clinical translation.
-
SB 431542: Protocol Optimization and Anti-Tumor Use Cases
2026-04-20
SB 431542 stands out as a potent ALK5 inhibitor, powering cell-based and immunomodulatory research platforms with precision TGF-β pathway control. This guide details applied protocols, advanced troubleshooting, and workflow insights directly informed by recent breakthroughs in cancer stem cell research.
-
Protease Inhibitor Cocktail: Precision in Protein Degradatio
2026-04-19
The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) delivers robust, broad-spectrum protection for sensitive protein workflows, outperforming generic inhibitors in Western blotting and co-immunoprecipitation. Its dual-component design targets key protease classes, ensuring preserved protein integrity for downstream molecular analyses.
-
PR-619 in Cellular Ubiquitination: Precision DUB Inhibition
2026-04-18
Explore how PR-619, a powerful deubiquitylating enzymes inhibitor, enables precise and controlled disruption of the ubiquitination pathway in advanced cellular models. This deep-dive reveals practical assay insights and highlights PR-619’s unique differentiation for cancer and neurodegenerative disease research.
-
PR-619: Practical Guide for DUB Inhibition in Cell-Based Ass
2026-04-17
PR-619 is a reversible, cell-permeable deubiquitylating enzymes inhibitor designed to disrupt DUB function and promote ubiquitinated protein accumulation without directly inhibiting proteasomal catalytic activity. It is best suited for cell-based ubiquitination pathway research, autophagy assays, and disease modeling in oncology and neurodegeneration. Use is not recommended where long-term solution stability or aqueous solubility is required.
-
Nirmatrelvir (PF-07321332): Structural Insights & Protocol P
2026-04-16
Explore the structural mechanism and precise assay protocols of Nirmatrelvir (PF-07321332), a leading SARS-CoV-2 3CL protease inhibitor. This article delivers unique, actionable guidance for antiviral therapeutics research, integrating recent molecular findings and practical lab recommendations.
-
CRISPRi Targeting Fabp4 in Adipocytes Ameliorates Obesity an
2026-04-15
This study pioneers a targeted CRISPR interference (CRISPRi) delivery system against Fabp4 in white adipocytes, demonstrating significant improvements in obesity, inflammation, hepatic steatosis, and insulin resistance in vivo. The work advances precision gene therapy strategies for metabolic disease and highlights the need for tissue-specific delivery systems in obesity research.
-
3X (DYKDDDDK) Peptide: Optimizing FLAG Tag Workflows in Rese
2026-04-14
The 3X (DYKDDDDK) Peptide empowers high-sensitivity detection and robust affinity purification of FLAG-tagged proteins, streamlining the study of complex proteins like mitoguardin-2. Discover step-by-step protocol enhancements, troubleshooting strategies, and advanced applications to maximize your experimental outcomes with this versatile epitope tag.
-
Protease Inhibitor Cocktail: Optimizing Protein Extraction W
2026-04-13
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) from APExBIO empowers researchers to achieve reliable protein degradation prevention without compromising downstream applications such as phosphorylation analysis. This article translates bench insights into actionable steps for maximizing assay fidelity, troubleshooting, and data reproducibility in modern protein science.
-
CTDNEP1-NEP1R1 Regulation of ER Lipid Synthesis and Storage
2026-04-13
This study reveals that CTD-nuclear envelope phosphatase 1 (CTDNEP1) depends on its regulatory subunit NEP1R1 for stability and function in restricting ER membrane synthesis, but not for regulating lipid storage in mammalian cells. These results clarify the differential regulation of ER lipid metabolism and provide a framework for dissecting protein homeostasis and lipid biogenesis interplay.